T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com

Research analysts at StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a note issued to investors on Tuesday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Trading Up 0.1 %

Shares of T2 Biosystems stock opened at $0.13 on Tuesday. The business’s fifty day simple moving average is $0.19 and its 200 day simple moving average is $0.84. T2 Biosystems has a 12 month low of $0.06 and a 12 month high of $6.80.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.